# Eikon Therapeutics, Inc.: Form S-1, filed Jan 9, 2026

- Company: [Eikon Therapeutics, Inc.](/companies/eikn.md) (CIK 1861123)
- Form: S-1
- Filed: 2026-01-09
- Accepted by EDGAR: Jan 9, 2026, 16:02 ET
- Period: not reported
- Accession: 0001193125-26-008888
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1861123/000119312526008888/d903262ds1.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1861123/000119312526008888/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1861123/000119312526008888/d903262ds1.htm

Filed Jan 9, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-008888. Last ingested by Listed: Nov 12, 2026, 17:35 ET. No prices; not investment advice.
